CD274 and infantile convulsions and choreoathetosis: In conclusion, our study indicated that, compared with SC, triple combination therapy of FOLFOX-HAIC, targeted therapy (TKIs) and immunotherapy (anti-PD-L1/PD-1) might be an effective and safe treatment for patients with advanced iCCA.